Platelet and plasma-derived clotting factor system

This entry collectively describes **platelets** (small anuclear fragments essential for initial wound plugging and activation of the coagulation response) and **plasma-derived clotting factors** (a group of enzymatic and regulatory proteins, such as fibrinogen, thrombin, factor VIII, and von Willebrand factor, that drive the cascade leading to stable clot formation). Both are manipulated therapeutically via transfusion to treat or prevent bleeding in conditions like trauma, surgical bleeding, inherited deficiencies (e.g., hemophilia), liver disease, and hematologic disorders. Such therapy is foundational in acute and chronic management of bleeding, with donor plasma and platelets often selected or modified to meet specific deficiency needs.

Other names

Platelet transfusionPlasma transfusionBlood clotting factor supportHemostatic therapy

Platelet transfusion: Restores primary hemostasis by physical plug formation and amplification of coagulation cascade. Plasma/Clotting factor transfusion: Supplies deficient or absent coagulation proteins, restoring secondary hemostasis and allowing normal clot formation.